Author

Ørnulf Borgan

University of OsloORCID 0000-0002-4687-1202Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Anita Langerød· 1 shared Anne‐Lise Børresen‐DaleiD· 1 shared Anthony MathelieriD· 1 shared Arne V. PladseniD· 1 shared Arnoldo FrigessiiD· 1 shared Camilla LingjærdeiD· 1 shared Carlos CaldasiD· 1 shared David C. WedgeiD· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Anita Langerød

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tailored Graphical Lasso for Data Integration in Gene Network Reconstruction

Camilla Lingjærde, Tonje Gulbrandsen Lien, Ørnulf Borgan, Ingrid K. Glad

The paper introduces a tailored graphical lasso method for gene network reconstruction that effectively integrates prior information, outperforming existing methods in simulated and real data.

bioRxiv · Dec 29, 2020 · PreprintBioinformatics

Copy number motifs expose genome instability type and predict driver events and disease outcome in breast cancer

Arne V. Pladsen, Gro Nilsen, Oscar M. Rueda, Miriam R. R. Aure, Ørnulf Borgan, Knut Liestøl, Valeria Vitelli, Arnoldo Frigessi, Anita Langerød, OSBREAC, Anthony Mathelier, Olav Engebråten, David C. Wedge, Peter Van Loo, Carlos Caldas, , Ole Christian Lingjærde

The paper identifies copy number motifs in breast cancer genomes that predict disease outcome and driver events, outperforming existing clinical and genomic markers.

bioRxiv · Sep 14, 2019 · PreprintBioinformatics